AMIODARONE-INDUCED THYROID DYSFUNCTION: CLINICAL CASE WITH LITERATURE REVIEW
Abstract
The article addresses the problem of amiodarone-induced thyroid dysfunction based in the clinical case. The literature data on the pathogenesis, diagnosis of this disease, as well as management tactics for different variants of amiodarone-associated thyroid dysfunction are shown.
Transient changes in thyroid function tests often occur in euthyroid individuals treated with amiodarone. Amiodarone causes predictable changes of tests that characterize the function of the thyroid gland, explicable in terms of physiological effects, caused by an iodine excess and its inhibition of deiodinase activity. Identify euthyroid hypothyroxinemia should not be considered as an indication for the abolition of amiodarone. While patients with pre-existing autoimmune thyroid disease (subclinical Hashimoto's thyroiditis or positive antithyroid antibodies) are at increased risk of developing amiodarone-induced hypothyroid-dism, most patients remain euthyroid during amiodarone therapy. Since small increases in serum TSH concentrations (10 to 20 mU/L) are seen in euthyroid patients for the first three to six months after amiodarone therapy is initiated, amiodarone-induced hypothyroidism should only be diagnosed when serum T4 concentrations are low-normal or low, or mild TSH elevation persists.
Downloads
References
Singh B. N. Amiodarone as paradigm for developing new drugs for atrial fibrillation / B.N. Singh // J Cardiovasc Pharmacol. – 2008. – № 4. – p. 300–305.
Hudzik B. Amiodarone-related thyroid dysfunction / B. Hudzik, B. Zubelewicz-Szkodzinska // Intern Emerg Med. – 2014. – № 9. – p. 829–839.
Loh K. C. Current concepts in medicine: Amiodarone-induced thyroid disorders: a clinical review / Loh Keh-Chuan // Postgrad Med J. – 2000. – № 893. – p. 133–140.
Rao R.H. Iodine kinetic studies during amiodarone treatment / R.H. Rao, V.R. McCready, G.S. Spathis // J Clin Endocrinol Metab. – 1986. – № 62. – p. 563–568.
Stanbury J. B. Iodine-induced hyperthyroidism: Occurrence and epidemiology / J.B. Stanbury, A.E. Ermans, P. Bourdoux et al. // Thyroid. – 1988. – № 8. – p. 83–100.
Narayana S. K. Management of Amiodarone-Related Thyroid Problems / S. K. Narayana, D. R. Woods, C. J. Boos // Ther Adv Endocrinol Metab. – 2011. – № 3. – p. 115–126.
Harjai K. J. Amiodarone-induced hyperthyroidism: A case series and brief review of literature / K. J. Harjai, A. A. Licata // Pacing Clin Electrophysiol. – 1996. – № 19. – p. 1548–1554.
Bogazzi F. Thyroid color flow Doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis / F. Bogazzi, E. Martino, E. Dell'Unto et al. // Eur J Endocrinol Invest. – 2003. – № 26. – p. 635–640.
Vanbeeren H. C. Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha-1 receptor protein / H. C. Vanbeeren, O. Bakker, W. Wiersinga // Mol Cell Endocrinol. – 1995. – № 112. – p. 15–19.
Braverman L. E. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease/L. E. Braverman, S. H. Ingbar, A. G. Vagenakis et al. //J Clin Endocrinol Metab. – 1971. - № 32. – p. 515–521
Amico J. A. Clinical and chemical assessment of thyroid function during therapy with amiodarone / J. A. Amico, V. Richardson, B. Alpert et al. // Arch. Intern. Med. – 1984. – №. 144. – p. 487–490.
Fradkin J. E. Iodide-induced thyrotoxicosis / J. E. Fradkin, J. Wolff // Medicine (Baltimore). – 1983. – № 62. – p.1–20
Trip M. D. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism / M. D. Trip, W. Wiersinga, T. A. Plomp // Am J Med. – 1991. - № 91. – p. 507–511
Nademanee K. Amiodarone and thyroid function / K. Nademanee. R. W. Piwonka, B. N. Singh // Hershman Prog Cardiovasc Dis. – 1989. – № 31. – p.427–437
Martino E. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases/ E. Martino, F. Aghini-Lombardi, S. Mariotti et al. Clin Endocrinol (Oxf). – 1987. – № 26. – p.227–237
Ursella S. Amiodarone-induced thyroid dysfunction in clinical practice / S. Ursella, A. Testa, M. Mazzone, N. Gentiloni Silveri // European Review for Medical and Pharmacological Sciences. – 2005. – № 10. – p. 269–278
Basaria S. Amiodarone and the thyroid / S. Basaria, D.S. Cooper // Am J Med. – 2005. – № 118. – p. 706–714
Newman C. M. Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy / C. M. Newman, A. Price, D. W. Davies et al. // Heart – 1998 – № 79. – p. 121–127
Siddoway L. A. Amiodarone: Guidelines for use and monitoring / L. A. Siddoway // Am Fam Phys. – 2003. – № 68. – p. 2189–2196
Martino E. Short term administration of potassium perchlorate restores euthyroidism in amiodarone-induced hypothyroidism / E. Martino, S. Mariotti, F. Aghini-Lombardi et al. // J Clin Endocrinol Metab. – 1986. – № 63. – p.1233–1236
van Dam E. W.Treatment of amiodarone-induced hypothyroidism with potassium perchlorate / E. W. van Dam, M. F. Prummel, W. M. Wiersinga, R. E. // Nikkels Neth J Med. – 1993. – № 42. – p. 21–24
De Groef B.Perchlorate versus other environmental sodium / iodide symporter inhibitors: potential thyroid-related health effects / B. De Groef, B. R. Decallonne, S. Van der Geyten et al // European Journal of Endocrinology. – 2006. – № 1. – p. 17–25
Martino E. Amiodarone: a common source of iodine-induced thyrotoxicosis / E. Martino, F. Aghini-Lombardi, S. Mariotti et al. // Horm Res. – 1987. – № 26. – p. 158–171.
Copyright (c) 2017 L. V. Bogun
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.